[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
February 1955

IDIOPATHIC HYPERLIPEMIA AND PRIMARY HYPERCHOLESTEREMIC XANTHOMATOSIS: V. Analysis of Serum Lipoproteins by Means of Ultracentrifuge Before and After Administration of Heparin

Author Affiliations


From the Department of Dermatology, Harvard Medical School, and the Dermatologic Service, Massachusetts General Hospital.

AMA Arch Derm. 1955;71(2):158-171. doi:10.1001/archderm.1955.01540260016005

IN A PREVIOUS communication of this series1 it had been reported that a single intravenous injection of 50 mg. of heparin consistently caused a slight decrease in serum cholesterol in primary hypercholesteremic xanthomatosis, and a slight decrease also in phospholipids, neutral fat, and turbidity in idiopathic hyperlipemia. Subsequently it was observed2 that the prolonged administration of heparin caused a considerable decrease in turbidity and in all the lipid values in idiopathic hyperlipemia.

In order to obtain information about the action of heparin on the serum lipoproteins, ultracentrifugal analyses of the lipoproteins were carried out before and after a single intravenous injection of 100 mg. of heparin in normal persons as well as in patients with primary hypercholesteremic xanthomatosis and idiopathic hyperlipemia. In addition, similar studies were carried out in several patients with idiopathic hyperlipemia before and during the prolonged administration of heparin.


Blood was collected as

References 4 and 5.
References 4, 5, and 6.
References 4, 5, and 15.
Lever, W. F.; Smith, P. A. J., and Hurley, N. A.:  Idiopathic Hyperlipemia and Primary Hypercholesteremic Xanthomatosis: III. Effect of Intravenously Administered Heparin on the Plasma Proteins and Lipids ,  J. Invest. Dermat. 22:71, 1954.Crossref
Lever, W. F.; Herbst, F. S. M., and Hurley, N. A.:  Idiopathic Hyperlipemia and Primary Hypercholesteremic Xanthomatosis: IV. Effects of Prolonged Administration of Heparin on Serum Lipids in Idiopathic Hyperlipemia ,  A. M. A. Arch. Dermat. this issue.
Lever, W. F.; Smith, P. A. J., and Hurley, N. A.:  Idiopathic Hyperlipemia and Primary Hypercholesteremic Xanthomatosis: I. Clinical Data and Analysis of the Plasma Lipids ,  J. Invest. Dermat. 22:33, 1954.Crossref
Gofman, J. W.; Jones, H. B.; Lindgren, F. T.; Lyon, T. P.; Elliot, H. A., and Strisower, B.:  Blood Lipids and Human Atherosclerosis ,  Circulation 2:161, 1950.Crossref
Gofman, J. W.; Jones, H. B.; Lyon, T. P.; Lindgren, F.; Strisower, B.; Colman, D., and Herring, V.:  Blood Lipids and Human Atherosclerosis ,  Circulation 5:119, 1952.Crossref
Gofman, J. W.; Lindgren, F. T.; Jones, H. B.; Lyon, T. P., and Strisower, B.:  Lipoproteins and Atherosclerosis ,  J. Gerontol. 6:105, 1951.Crossref
McGinley, J.; Jones, J., and Gofman, J. W.:  Lipoproteins and Xanthomatous Diseases ,  J. Invest. Dermat. 19:71, 1952.Crossref
Biggs, M. W., and Colman, D.:  A Quantitative Metabolic Defect in Lipid Metabolism Associated with Abnormal Lipoproteins in Man ,  Circulation 7:393, 1953.Crossref
Wheeler, E. O., and Sprague, H. B.:  The Prevalence and Significance of Hypercholesteremia Among Children and Siblings of Patients with Hypercholesteremic Xanthomatosis ,  J. Clin. Invest. 32:611, 1953.
Epstein, N. N.; Rosenman, R. H., and Gofman, J. W.:  Serum Lipoproteins and Cholesterol Metabolism in Xanthelasma ,  A. M. A. Arch. Dermat. & Syph. 65:70, 1952.
Graham, D. M.; Lyon, T. P.; Gofman, J. W.; Jones, H. B.; Yankley, A.; Simonton, J., and White, S.:  Blood Lipids and Human Atherosclerosis: II. The Influence of Heparin upon Lipoprotein Metabolism ,  Circulation 4:666, 1951.
Loewe, L.; Richmond, G.; Brown, R.; Lesser, R. P.; Cohen, C., and Cox, H.:  The Effect of Repository Heparin upon Lipoprotein Patterns in Human Beings ,  Angiology 4:295, 1953.
Rinzler, S. H.; Travell, J.; Bakst, H.; Benjamin, Z. H.; Rosenthal, R. L.; Rosenfeld, S., and Hirsch, B. B.:  Effect of Heparin in Effort Angina ,  Am. J. Med. 14:438, 1953.
Gofman, J. W.:  Lipoprotein Transformations in Health and Disease ,  Educ. Proc. Permanente Hosp. 2:174, 1952.
Jones, H. B.; Gofman, J. W.; Lindgren, F. T.; Lyon, T. P.; Graham, D. M.; Strisower, B., and Nichols, A. V.:  Lipoproteins and Atherosclerosis ,  Am. J. Med. 11:358, 1951.
Herzstein, J.; Wang, C.-I., and Adlersberg, D.:  Effect of Heparin on Plasma Lipid Partition in Man: Studies in Normal Persons and in Patients with Coronary Atherosclerosis, Nephrosis and Primary Hyperlipemia ,  Ann. Int. Med. 40:290, 1954.
Shore, B.; Nichols, A. V., and Freeman, N. K.:  Evidence for Lipolytic Action by Human Plasma Obtained after Intravenous Administration of Heparin ,  Proc. Soc. Exper. Biol. & Med. 83: 216, 1953.
Pierce, F. T., Jr.:  The Interconversion of Serum Lipoproteins in Vivo ,  Metabolism 3:142, 1954.